IAPP and type 2 diabetes mellitus: Thus, autophagy–lysosomal degradation defends β cells against proteotoxicity induced by oligomerization-prone human IAPP, and as such hIAPP-induced autophagy impairment may facilitate β-cell dysfunction in the development of T2DM (also see [296]).